Evageliou, Nicholas F <br/><br/>
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2016 
 - 4391-404 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-15-2539  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Celecoxib--pharmacology<br/>Cell Line, Tumor<br/>Cell Transformation, Neoplastic--drug effects<br/>Disease Models, Animal<br/>Disease Progression<br/>Drug Evaluation, Preclinical<br/>Drug Synergism<br/>Eflornithine--pharmacology<br/>Genes, myc<br/>Homeostasis--drug effects<br/>Humans<br/>Mice<br/>Mice, Transgenic<br/>Neuroblastoma--drug therapy<br/>Oncogene Proteins--genetics<br/>Polyamines--antagonists & inhibitors<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays